Indications for Chorionic gonadotropin:
Ovulation induction in women with secondary ovarian failure who have been pretreated with human gonadotropins.
5000–10000 Units IM one day after last dose of gonadotropins.
Androgen- or estrogen-dependent neoplasm. Ovarian enlargement and overstimulation while on gonadotropin therapy. Primary ovarian failure.
Cardiac or renal disease. Epilepsy. Migraine. Asthma. Pregnancy (Cat.C). Nursing mothers.
Ovarian hyperstimulation or enlargement, ascites, pleural effusion, ovarian cyst rupture, multiple births, arterial thromboembolism, headache, irritability, restlessness, depression, fatigue, edema, gynecomastia, local reactions.
Formerly known under the brand name Novarel.